Search

Search results

10 results found

Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-density Lipoprotein Receptor Degradation

Zhu, Bo, Krishan Gupta, Kui Cui, Beibei Wang, Marina V. Malovitchko, Kathryn S. Li, Hao Wu, et al. 2024. “Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-Density Lipoprotein Receptor Degradation”. BioRxiv 2024.08.26.609742.